John Sweetenham, MD

Articles by John Sweetenham, MD

Dr. Sweetenham on Unanswered Questions With CAR T-Cell Therapy in Pediatric ALL

June 1st 2019

John Sweetenham, MD, associate director for clinical affairs, Harold G. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, discusses unanswered questions with CAR T-cell therapy in pediatric acute lymphoblastic leukemia.

Latest Updated Articles

Dr. Sweetenham on Unanswered Questions With CAR T-Cell Therapy in Pediatric ALL
Published: June 1st 2019 | Updated:

John Sweetenham, MD

Articles by John Sweetenham, MD

Dr. Sweetenham on Unanswered Questions With CAR T-Cell Therapy in Pediatric ALL

Latest Updated Articles

Trending on CGTlive®

Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks

CGTLive®’s Weekly Rewind – October 17, 2025